Log in to save to my catalogue

Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolle...

Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolle...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1927872660

Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial

About this item

Full title

Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial

Publisher

England: Elsevier Ltd

Journal title

Lancet neurology, 2017-09, Vol.16 (9), p.712-720

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Mucopolysaccharidosis type IIIB syndrome (also known as Sanfilippo type B syndrome) is a lysosomal storage disease resulting in progressive deterioration of cognitive acquisition after age 2–4 years. No treatment is available for the neurological manifestations of the disease. We sought to assess the safety and efficacy of a novel intracerebral gen...

Alternative Titles

Full title

Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1927872660

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1927872660

Other Identifiers

ISSN

1474-4422

E-ISSN

1474-4465

DOI

10.1016/S1474-4422(17)30169-2

How to access this item